Public Hearing Will Focus on CDER's Risk-Communication Strategies

Drug Industry Daily
KEYWORDS FDA
A A

The Center for Drug Evaluation and Research’s (CDER) risk communication strategy for human drugs will be the topic of a two-day public hearing in early December that will focus on collecting public feedback on the effectiveness of the center’s communication activities.

To View This Article:

Login

Subscribe To Drug Industry Daily